Reading a label

When The Advert Names Six Ingredients And The Label Names Nine

Horse Boost ships with two listing graphics that name six botanicals. The Supplement Facts panel on the bottle names nine. Neither document is lying, and the gap between them is the most useful thing a buyer can learn about how supplement marketing is put together.

By Horse Boost Team · Last updated September 19, 2026 · 8 min read · Reading a label · Reviewed by Dr. Ashley Tapscott, MD

Two documents that are not the same kind of thing

A Supplement Facts panel is a regulated disclosure. Its content, its order and its format are set out in federal rule, and 21 CFR 101.36 specifies what has to appear on it and how. A manufacturer who leaves an ingredient off it has a compliance problem.

A listing graphic is an advertisement. It has a layout, a word count, an art director and a marketing objective, and the only rule that governs it is that it must not be misleading, which is the territory covered by the FTC's health products compliance guidance. Nothing requires it to be complete.

Those two facts are enough to resolve almost every disagreement a buyer will ever find between a supplement's packaging and its marketing. The panel is the document the manufacturer had to get right. The graphic is the document somebody wanted to look good.

Six names on two separate listing graphics, nine on the bottle. The three missing from the advertising are the eighth, the ninth and the only one with a printed amount.

The gap, name by name

Read the table above from the bottom and the shape of it is clear. The three names absent from the advertising are the eighth and ninth on the panel, plus caffeine.

Panel order is not arbitrary. Ingredients inside a proprietary blend are listed in descending order of predominance, so the eighth and ninth names are the two smallest contributors to an 82 mg total. Whatever else is true, tribulus and horny goat weed are the least of what is in this gummy by weight.

Caffeine is the odd one out and its absence from the graphics is the least defensible of the three, because it is the one name on this panel with a printed amount. Five milligrams is a small figure and it is still the only figure, and a buyer counting stimulant intake would want it in front of them before they reached the bottle.

• Panel order carries information. First name, largest share. Ninth name, smallest.
• An omission is not a contradiction. Nothing on the graphic says these are the only ingredients.
• Caffeine is the one that matters practically. The other two are botanical names among eight.
• Nine names sharing 82 mg is the real story. Whether it is six or nine, the total does not move.

Four explanations, and which one would matter

Speculating about a marketing department's reasoning is not worth much, but laying out the possibilities is, because only one of them would be a reason to worry.

Only the last row would be a problem with the product. The other three are problems with the advertising, which is a different thing and a smaller one.

The layout explanation is the dullest and probably the right one. Both graphics use a six-box arrangement, three boxes down each side of a product shot, and nine names do not fit a six-box arrangement without redrawing it. That is how a great deal of advertising copy gets decided.

The only version that would be a product problem is a panel that does not describe the contents, and nothing here suggests that. A panel is the regulated document and there is no reason to treat the advertisement as a correction to it.

What the three omitted names actually carry

Two of the three have research records that a marketing department would not enjoy, which is worth stating because a reader will wonder about it.

Tribulus terrestris

A 2025 review of ten studies in 483 men found doses of 400 to 750 mg a day improved erectile dysfunction in three of the five studies that measured it, while eight of the ten reported no significant change in androgen profile, and rated half the studies low quality. Tribulus is widely sold as a testosterone ingredient and that is the finding behind it.

Horny goat weed extract

Its flavonoid, icariin, inhibits phosphodiesterase-5 in a test tube; the clearest publication is an isolation of PDE5A-inhibiting flavonoids from Epimedium. There is no modern human trial record worth quoting for this use, which is a sentence that belongs on a label discussion rather than in an advertisement.

Caffeine

Nothing unflattering at all, which is what makes its absence from the graphics the odd one. Five milligrams is trivially small and printing it is a point in the label's favour.

Where else this gap shows up in the aisle

Once you start checking, the same discrepancy turns up in four predictable places, and all four are worth a glance before a purchase rather than after one.

• Ingredient counts. The panel and the advertising disagree about how many names there are, which is the case here. Usually the advertising has fewer.
• Serving counts. A front panel says one number of gummies and the Servings Per Container line says another. On this bottle both say thirty, which is the outcome you want and not the one you should assume.
• Amounts. A product page quotes a milligram figure that appears nowhere on the panel, usually because it is a figure for an ingredient studied elsewhere rather than a figure for this product.
• Claims. The imagery implies something the printed phrases do not say. This pack ships an intimacy photograph and the bottle mentions no such thing.

Three of those four are ordinary marketing untidiness and the third is the serious one. A milligram figure quoted in an advertisement but absent from the panel is the version of this problem worth asking about, because the panel is the document that would have to carry it if it were true of the product.

The short rule: when a page and a panel disagree about a count or a name, believe the panel and carry on. When they disagree about an amount, stop and ask.

The habit worth taking from this

Read the panel first and the marketing second, on every product in this aisle. It takes thirty seconds and it resolves the majority of what a shopper would otherwise have to take on trust.

1. Find the Supplement Facts block and count the names under any blend heading.
2. Count the names in the advertising. Note the difference in either direction.
3. Check whether any name carries its own figure. That is the only number you can act on.
4. Read the blend total and divide it by the number of names for the honest average.
5. If the advertising names something the panel does not, that is the serious direction of the two, and it is worth a question to the seller.

The last point deserves its own sentence. An advertisement naming fewer ingredients than the panel is an incomplete advertisement. An advertisement naming an ingredient the panel does not carry is a different matter entirely, and it is the one worth raising with whoever is selling it.

What a proprietary blend cannot do in either case is tell you how much of anything is present. The paper on what blend declarations leave a reader with states it plainly: the amount of an individual ingredient is not available from the label, so it cannot be used to estimate intake or compared with a trial dose. Six names or nine, that limit is the same.

This desk sells this product, which is exactly why the count is printed as nine everywhere on this website rather than as six. A page that repeated the advertisement would be easier to write and would be worth less than the paper it is not printed on.

References